Iradimed Co Stock Alpha and Beta Analysis
IRMD Stock | USD 53.58 0.83 1.57% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Iradimed Co. It also helps investors analyze the systematic and unsystematic risks associated with investing in Iradimed over a specified time horizon. Remember, high Iradimed's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Iradimed's market risk premium analysis include:
Beta 1.62 | Alpha (0.0004) | Risk 2.17 | Sharpe Ratio 0.11 | Expected Return 0.24 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Iradimed |
Iradimed Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Iradimed market risk premium is the additional return an investor will receive from holding Iradimed long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Iradimed. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Iradimed's performance over market.α | -0.0004 | β | 1.62 |
Iradimed expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Iradimed's Buy-and-hold return. Our buy-and-hold chart shows how Iradimed performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Iradimed Market Price Analysis
Market price analysis indicators help investors to evaluate how Iradimed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Iradimed shares will generate the highest return on investment. By understating and applying Iradimed stock market price indicators, traders can identify Iradimed position entry and exit signals to maximize returns.
Iradimed Return and Market Media
The median price of Iradimed for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 49.43 with a coefficient of variation of 5.76. The daily time series for the period is distributed with a sample standard deviation of 2.89, arithmetic mean of 50.11, and mean deviation of 2.26. The Stock received a lot of media exposure during the period. Price Growth (%) |
Timeline |
1 | IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth Big 8 Investor Conference | 09/10/2024 |
2 | Disposition of 1767 shares by Scharen-guivel Hilda Frederique of Iradimed subject to Rule 16b-3 | 10/14/2024 |
3 | Disposition of 219 shares by Hawkins James B of Iradimed at 43.6137 subject to Rule 16b-3 | 10/16/2024 |
4 | Iradimed Corporation Sees Large Growth in Short Interest | 10/17/2024 |
5 | Iradimed Hits New 52-Week High Still a Buy | 10/23/2024 |
6 | Iradimed Scheduled to Post Quarterly Earnings on Thursday | 10/30/2024 |
7 | IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of 0.15 Per Share | 10/31/2024 |
8 | iRadimed Corp Q3 2024 Earnings Call Highlights Record Revenue Growth and Strategic Shifts | 11/01/2024 |
9 | IRADIMED CORPORATION Named to Fortunes 100 Fastest Growing Companies List for 2024 | 11/04/2024 |
10 | iRadimed Corp Stock Price Up 3.61 percent on Nov 5 | 11/05/2024 |
11 | Disposition of 2690 shares by Vuoto Anthony of Iradimed at 55.9911 subject to Rule 16b-3 | 11/06/2024 |
12 | iRadimed is on the Move, Heres Why the Trend Could be Sustainable | 11/07/2024 |
13 | Acquisition by Scharen-guivel Hilda Frederique of 1767 shares of Iradimed subject to Rule 16b-3 | 11/15/2024 |
Iradimed dividend paid on 25th of November 2024 | 11/25/2024 |
14 | Is There An Opportunity With IRADIMED CORPORATIONs 47 percent Undervaluation | 11/26/2024 |
About Iradimed Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Iradimed or other stocks. Alpha measures the amount that position in Iradimed has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
2023 | 2024 (projected) | Dividend Yield | 0.0221 | 0.0316 | Price To Sales Ratio | 9.13 | 9.61 |
Iradimed Upcoming Company Events
As portrayed in its financial statements, the presentation of Iradimed's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Iradimed's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Iradimed's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Iradimed. Please utilize our Beneish M Score to check the likelihood of Iradimed's management manipulating its earnings.
1st of February 2024 Upcoming Quarterly Report | View | |
2nd of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
1st of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Iradimed
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Iradimed Backtesting, Iradimed Valuation, Iradimed Correlation, Iradimed Hype Analysis, Iradimed Volatility, Iradimed History and analyze Iradimed Performance. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Iradimed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.